Neel, Dana S.

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

Lin, L., Sabnis, A. J., Chan, E., Olivas, V., Cade, L., Pazarentzos, E., Asthana, S., Neel, D., Yan, J. J., Lu, X., et al. (2015) · Nature Genetics

Hippo pathway signaling and YAP/TAZMelanoma and MAPK Pathways

Cited by 551

Dynamics and Memory of Heterochromatin in Living Cells

Hathaway, N. A., Bell, O., Hodges, C., Miller, E. L., Neel, D. S., & Crabtree, G. R. (2012) · Cell

Genomics and Chromatin DynamicsEpigenetics and DNA Methylation

Cited by 446

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Blakely, C. M., Pazarentzos, E., Olivas, V., Asthana, S., Yan, J. J., Tan, I., Hrustanovic, G., Chan, E., Lin, L., Neel, D. S., et al. (2015) · Cell Reports

Lung Cancer Treatments and MutationsNF-κB Signaling Pathways

Cited by 204

Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules

Tulpule, A., Guan, J., Neel, D. S., Allegakoen, H. R., Lin, Y. P., Brown, D., Chou, Y.-T., Heslin, A., Chatterjee, N., Perati, S., et al. (2021) · Cell

Protein Kinase Regulation and GTPase SignalingRNA Research and Splicing

Cited by 189

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma

Neel, D. S., & Bivona, T. G. (2017) · npj Precision Oncology

Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics

Cited by 98